Stockhouse

Parallax Receives Approval on its Registration Into U.S. Government's System for Award Management, (SAM)

Patented and FDA Approved Diagnostics Platform Subject of Application for Contract Grant with U.S. Center for Disease Control, (CDC) NEW YORK, NY, March 16, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE ‒ ...
Stockhouse

Parallax Diagnostics Partners with CURE Pharmaceuticals to Distribute Individually Sealed CUREfilm® D for Medical and Critical Services Workers

COVID-19 Coronavirus Infection Risk May be Reduced by Weekly Dose of Vitamin D3 NEW YORK, NY, April 07, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Parallax Health Sciences, Inc. (OTCQB: PRLX) ...
EurekAlert!

PARALLAX meets one primary endpoint in heart failure with preserved ejection fraction

Sophia Antipolis, France - 30 Aug 2020: Sacubitril/valsartan reduces NT-proBNP, a biomarker predictive of long-term clinical outcomes in heart failure, but does not improve functional capacity ...
Nasdaq

Parallax Reaffirms Previously Released Statement

This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All ...